[EN] ESTROGENIC COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS ŒSTROGÉNIQUES ET MÉTHODES D'UTILISATION
申请人:[en]IATERION, INC.
公开号:WO2024026034A1
公开(公告)日:2024-02-01
Estrogenic compounds, compositions and method are presented. The novel estrogenic compounds comprise novel chalcone derivatives and analogs that have little or no measurable estrogen (estradiol, E2) activity but potentiate E2 activity without binding an estrogen receptor (ER). The novel compositions comprise one or more of the novel estrogenic compounds, and may optionally comprise one or more excipients. The one or more excipients may be pharmaceutically acceptable. The one or more excipients may comprise at least one compound that does not occur in nature with estrogenic compounds. The method comprises administering a pharmaceutical composition comprising an estrogenic compound described herein to a patient in need of treatment with an estrogenic compound or pharmaceutical composition.
A synthesis of aaptamine
作者:T. Ross Kelly、Martin P. Maguire
DOI:10.1016/s0040-4020(01)96655-4
日期:1985.1
A five-step synthesis of the unusual marine alkaloid aaptamine () from veratrole is described (Scheme 1).